Research shows why cancer stops responding to kinase-blocking drugs and comes back stronger

Research shows why cancer stops responding to kinase-blocking drugs and comes back stronger
More than 70 FDA-approved cancer drugs are kinase inhibitors, which work by blocking kinases — enzymes that add phosphate groups to molecules in the cell — and preventing the chemical activity necessary for signaling and growth in cancer cells…

Published March 13, 2023 at 01:45PM
Read more at nsf.gov